Albuterol and Ipratropium |
Combivent; DuoNeb |
Article: Ipratropium/salbutamol
The combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.
| Medications commonly used in asthma and COPD edit |
|---|
| Anticholinergics – ipratropium, tiotropium |
| β2-agonists – salbutamol, salmeterol, formoterol, terbutaline |
| Corticosteroids – budesonide, beclometasone, fluticasone |
| Combination products – budesonide/formoterol, fluticasone/salmeterol, ipratropium/salbutamol |
| Leukotriene receptor antagonists – montelukast, zafirlukast |
| Miscellaneous – aminophylline, cromoglicate, nedocromil, theophylline |
Categories: Pharmacology stubs | Bronchodilators
Resources
- Albuterol and Ipratropium (Drug Digest)
- Combivent (Drug Digest)

Not Signed In -

